Skip to main content

News

Press Release
10/31/2016
Transseptal Solutions, developer of a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation to treat multiple clinical indications, announced that the company has received its first CE-Mark for its...
Transseptal Solutions, developer of a new steerable sheath with a novel approach of transseptal puncture and left atrial navigation to treat multiple clinical indications, announced that the company has received its first CE-Mark for its...
Transseptal Solutions, developer...
10/31/2016
EP Lab Digest
Press Release
10/31/2016
CardioFocus, Inc. announced the appointment of Omari Bouknight as Chief Commercial Officer and Jeff Rynbrandt as Vice President of U.S. Sales. Together they will lead the commercialization of the HeartLight® Endoscopic Ablation System, which...
CardioFocus, Inc. announced the appointment of Omari Bouknight as Chief Commercial Officer and Jeff Rynbrandt as Vice President of U.S. Sales. Together they will lead the commercialization of the HeartLight® Endoscopic Ablation System, which...
CardioFocus, Inc. announced the...
10/31/2016
EP Lab Digest
Press Release
10/31/2016
BioTrace Medical Inc., an innovator in the development of temporary pacing technology, announced positive clinical results from a study of the company’s Tempo® Lead designed for use in procedures in which temporary pacing is...
BioTrace Medical Inc., an innovator in the development of temporary pacing technology, announced positive clinical results from a study of the company’s Tempo® Lead designed for use in procedures in which temporary pacing is...
BioTrace Medical Inc., an...
10/31/2016
EP Lab Digest
Press Release
10/24/2016
AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG) technology for mobile devices, announced a collaboration with Mayo Clinic to utilize AliveCor's unique measurement technology to unlock previously hidden health indicators in...
AliveCor, the leader in FDA-cleared mobile electrocardiogram (ECG) technology for mobile devices, announced a collaboration with Mayo Clinic to utilize AliveCor's unique measurement technology to unlock previously hidden health indicators in...
AliveCor, the leader in...
10/24/2016
EP Lab Digest
Press Release
10/24/2016
St. Jude Medical, Inc., a global medical device company, announced that it will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics educational meeting in...
St. Jude Medical, Inc., a global medical device company, announced that it will have new data featured during late-breaking clinical trial presentations at the upcoming 2016 Transcatheter Cardiovascular Therapeutics educational meeting in...
St. Jude Medical, Inc., a global...
10/24/2016
EP Lab Digest
Press Release
10/24/2016
Boston Scientific announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Washington, D.C., on October 29 – November...
Boston Scientific announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Washington, D.C., on October 29 – November...
Boston Scientific announced key...
10/24/2016
EP Lab Digest
Press Release
10/24/2016
Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer, announced results of two new real-world studies confirming the positive benefit-risk profile of XARELTO® (rivaroxaban) in treating venous thromboembolism (VTE), or...
Janssen Pharmaceuticals, Inc. (Janssen) and its development partner, Bayer, announced results of two new real-world studies confirming the positive benefit-risk profile of XARELTO® (rivaroxaban) in treating venous thromboembolism (VTE), or...
Janssen Pharmaceuticals, Inc....
10/24/2016
EP Lab Digest
Press Release
10/13/2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI)...
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and leads to be scanned in both 3 and 1.5 Tesla (T) magnetic resonance imaging (MRI)...
Medtronic plc is the first...
10/13/2016
EP Lab Digest
Press Release
10/05/2016
Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced that Ronald Reagan UCLA Medical Center in Los Angeles has installed the latest Niobe® ES remote magnetic navigation...
Stereotaxis, Inc., a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced that Ronald Reagan UCLA Medical Center in Los Angeles has installed the latest Niobe® ES remote magnetic navigation...
Stereotaxis, Inc., a global...
10/05/2016
EP Lab Digest
Press Release
10/05/2016
St. Jude Medical, Inc., a global medical device company, announced a full market release of its EnSite Precision™ cardiac mapping system and new Sensor Enabled™ tools in Europe. The new platform is now installed and active in more than 100...
St. Jude Medical, Inc., a global medical device company, announced a full market release of its EnSite Precision™ cardiac mapping system and new Sensor Enabled™ tools in Europe. The new platform is now installed and active in more than 100...
St. Jude Medical, Inc., a global...
10/05/2016
EP Lab Digest